Ailyn Irvita Ravinther

Ms. Ailyn Irvita Ravinther

Universiti Tunku Abdul Rahman, Kuala Lumpur, Malaysia
+1
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
ARAilyn Irvita Ravinther
Ailyn Irvita Ravinther
HDHemaniswarri Dewi Dewadas
Hemaniswarri Dewi Dewadas
STShi Ruo Tong
Shi Ruo Tong
CFChai Nien Foo
Chai Nien Foo
YLYu-En Lin
Yu-En Lin
YLYang Mooi Lim
Yang Mooi Lim
Parkinson’s disease is one of the most common neurodegenerative diseases affecting the ageing population, with a prevalence that has doubled over the last 30 years. As the mechanism of the disease is not fully elucidated, the current treatments are unable to effectively prevent neurodegeneration. Studies have found that mutations in Leucine-rich-repeat-kinase 2 (LRRK2) are the most common cause of familial Parkinson’s disease (PD). Moreover, aberrant (higher) LRRK2 kinase activity has an influence in idiopathic PD as well. Hence, the aim of this review is to categorize and synthesize current information related to LRRK2-linked PD and present the factors associated with LRRK2 that can be targeted therapeutically. A systematic review was conducted using the databases PubMed, Medline, SCOPUS, SAGE, and Cochrane (January 2016 to July 2021). Search terms included “Parkinson’s disease”, “mechanism”, “LRRK2”, and synonyms in various combinations. The search yielded a total of 988 abstracts for initial review, 80 of which met the inclusion criteria. Here, we emphasize molecular mechanisms revealed in recent in vivo and in vitro studies. By consolidating the recent updates in the field of LRRK2-linked PD, researchers can further evaluate targets for therapeutic application.

30 September 2026 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Closed access
ARAilyn Irvita Ravinther
Ailyn Irvita Ravinther
HDHemaniswarri Dewi Dewadas
Hemaniswarri Dewi Dewadas
RHRuijia Hou
Ruijia Hou
NLNicole Tze Er Lee
Nicole Tze Er Lee
CCCheng-Ting Chien
Cheng-Ting Chien
YLYang Mooi Lim
Yang Mooi Lim
Purpose: Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a progressive loss of dopaminergic neurons. PD is typically diagnosed at late-stage, concurrent with loss of up to 70% of these neurons so patient care could be improved by diagnosis at prodromal stages. The occurrence of Parkinsonian-like diseases also understores the importance of accurate differential diagnosis, yet no biomarkers are currently used in clinical settings to minimize diagnostic errors. The Rab family of GTPases has been implicated in the PD pathogenesis, with protein levels elevated in pre-clinical models. This review evaluates the utility of Rab proteins as a biomarker for PD. Methods: A systematic search was performed following PRISMA guidelines using PubMed, Scopus, Cochrane, SAGE, OVID and Web of Science (references up to November 2025). Search keywords included: "Parkinson", "Rab" and "biomarker". Results: Out of 1404 records identified, 27 articles were sought for retrieval after duplicate removal and title/abstract screening. The search yielded 13 articles that fit the inclusion criteria. 8 different Rab proteins of interest and/or their phosphorylated forms were reported as differentially expressed in PD patients in these papers. Of the 8 Rab proteins, Rab35 had a consistent elevation. However, this was observable from a single research group, presenting the need for independent validation of Rab35 as a diagnostic biomarker for idiopathic PD (iPD). In contrast, though preliminary, pRab10 may have relevance for patient stratification and monitoring drug response in PD patients. However, with the small evidence base, further research with larger sample sizes, patient sub-types and other contributing factors will be vital before integration into clinical practice. Conclusion: Overall, the evidence for Rab proteins as diagnostic biomarkers is emerging rather than established. Inconsistent reporting, small and frequently overlapping samples prevented quantitative synthesis.